Shots:
- Assertio Holdings’ Board has approved a definitive agreement with Zydus Worldwide DMCC, a subsidiary of Zydus, to acquire all outstanding Assertio shares, delisting it from the Nasdaq
- Assertio’s Board determined Zydus’ proposal constituted a “Superior Proposal” under the Garda merger agreement & authorized termination of the Garda transaction
- As per the deal, Zydus will acquire Asserio for $23.50 per share in cash, representing a total transaction value of ~$166.4M, with remaining shares acquired later via a second-step merger; closing is expected in Q2’26
Ref: Businesswire | Image: Assertio | Press Release
Related News: Garda to Acquire Assertio for ~$125.1M Upfront
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
